Idorsia Pharmaceuticals

Idorsia: A Leader in Biopharmaceutical Research and Development

About Idorsia

A Swiss Pharmaceutical Pioneer

Headquartered in Switzerland, the heart of Europe's biotech industry, Idorsia is a cutting-edge biopharmaceutical company dedicated to developing innovative medicines for unmet medical needs.

Our focus lies in the discovery, development, and commercialization of breakthrough treatments in various therapeutic areas, including CNS (central nervous system) and cardiovascular diseases.

Research and Development Excellence

Idorsia boasts a robust and diversified clinical development pipeline, spanning a range of therapeutic areas. Our unwavering commitment to R&D drives our pursuit of novel therapies that improve patient outcomes.

Contact Information

For inquiries, please reach out to us at One Radnor Corporate Center Suite 101, 100 Matsonford Rd, Radnor, PA 19087 or call 888 971-7050.